Psychiatry · New York, NY
NPI
1558579771
Since 2007
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1 Gustave L Levy Pl, Box 1230
New York, NY, 10029
Phone (212) 659-8734
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$48K
327 prescriptions
Company payments, 2023
$13.9
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Martin M Evers prescribed most often to Medicare patients was Sertraline Hcl, with 43 prescriptions and refills. In total Martin M Evers wrote 327 Medicare prescriptions that cost $48K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Sertraline Hcl Generic | 43 | 83 | Under 11 | $514 |
| Clonazepam Generic | 36 | 36 | Under 11 | $277 |
| Zolpidem Tartrate Generic | 33 | 33 | Under 11 | $522 |
| Lorazepam Generic | 30 | 30 | Under 11 | $258 |
| Xanax Alprazolam | 26 | 26 | Under 11 | $28K |
| Escitalopram Oxalate Generic | 20 | 60 | Under 11 | $396 |
| Bupropion Xl Bupropion Hcl | 18 | 22 | Under 11 | $451 |
| Quetiapine Fumarate Er Quetiapine Fumarate | 16 | 18 | Under 11 | $135 |
| Duloxetine Hcl Generic | 16 | 24 | Under 11 | $288 |
| Quetiapine Fumarate Generic | 11 | 19 | Under 11 | $64.64 |
| Fluoxetine Hcl Generic | 11 | 15 | Under 11 | $150 |
| Nortriptyline Hcl Generic | 11 | 11 | Under 11 | $133 |
Brand drugs: 37 claims; generic drugs: 290 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Martin M Evers $13.9 ($13.9 in general payments such as food, travel and fees) from 1 company. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $13.9.
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $13.9 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.